packageAdalimumab

adalimumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Adalimumab is a monoclonal antibody that blocks tumour necrosis factor alpha and is used to treat inflammatory conditions such as rheumatoid and other arthritis, psoriasis, ankylosing spondylitis, uveitis, ulcerative colitis, Crohn's disease, and hidradenitis suppurativa. It is widely used and authorised in the European Union, where several products are approved, though some have been withdrawn.

Summary written by glm-5.3-flash from Wikidata Q348260 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:adalimumab
ATC codes:L04AA17, L04AB04
DrugBank:DB00051
Wikidata:Q348260
molar mass:144190 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown